Risk of cardiovascular events in patients with metabolic syndrome: Results of a population-based prospective cohort study (PURE Turkey)

Date
2020
Author
Tumerdem, Burcu Calik
Yusuf, Salim
Temizhan, Ahmet
KESKİNLER, MİRAÇ VURAL
Rangarajan, Sumathy
OĞUZ, AYTEKİN
Kilickap, Mustafa
Gulec, Sadi
Altuntas, Yuksel
Karsidag, Kubilay
Metadata
Show full item record
Abstract
Objective: Metabolic syndrome (MetS) includes several cardiovascular (CV) risk factors. This study aimed to assess CV risk of MetS, contribution of its components to the risk, and whether MetS provides additional risk beyond its components.
URI
http://hdl.handle.net/20.500.12627/3643
https://doi.org/10.14744/anatoljcardiol.2020.27227
Collections